2024 Outcomes - Baylor Scott & White Heart and Vascular Hospital Fiscal year 2024 | Page 20

• Same day diagnostic testing and evaluation
• Advanced imaging using 1.5 Tesla MRI and / or 384-slice CT
• Access to major clinical trials
• Shared decision making between the center ’ s clinical team and patient regarding open surgical versus minimally invasive intervention
• Physicians participating in the center proctor cases internationally for TAVR devices
18
Baylor Scott & White Heart and Vascular Hospital — Dallas | Advanced Cardiovascular Centers
YEAR IN REVIEW
FY24

1,894

TAVRs since 2011

155

TAVR cases

173

Percutaneous mitral valve procedures since 2011

2 days

Median length of stay *

0 %

Commercial TAVR in-hospital observed mortality rate *
Center for Valve Disorders
The Center for Valve Disorders at Baylor Scott & White Heart and Vascular Hospital – Dallas specializes in comprehensive evaluation , diagnosis and treatment of patients with any type of valvular heart disease or structural heart issue .
The multidisciplinary team of interventional cardiologists , non-invasive cardiologists , cardiothoracic surgeons , and cardiac imaging specialists on the medical staff combine evidence-based expertise with advanced technology to address all valvular pathologies .
Patient advantages :

• Same day diagnostic testing and evaluation

• Advanced imaging using 1.5 Tesla MRI and / or 384-slice CT

• Access to major clinical trials

• Shared decision making between the center ’ s clinical team and patient regarding open surgical versus minimally invasive intervention

• Physicians participating in the center proctor cases internationally for TAVR devices

High Performing - TAVR
In its 2024-2025 “ America ’ s Best Hospitals ” list , U . S . News & World Report recognized Baylor Scott & White Heart and Vascular Hospital — Dallas by rating the hospital as High Performing in Transcatheter Aortic Valve Replacement ( TAVR ).

0 %

Minimally invasive mitral valve repair in-hospital mortality rate
* STS / ACC / TVT Registry Institutional Outcomes Report 2024 Q1 R4Q .